We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Hershey
HSY
$35.4B
| $23.4M | 0.05% |
+105,960
| New | +$23.7M |
|
402
Danaos Corp
DAC
$2.55B
| $23.2M | 0.05% |
417,531
-91,691
| -18% | -$6.09M |
|
403
Marathon Petroleum
MPC
$90.3B
| $23.2M | 0.05% |
233,910
-1,052,801
| -82% | -$98.6M |
|
|
GHIX
404
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $23.1M | 0.05% |
2,387,493
+330,000
| +16% | +$3.19M |
|
405
Hyatt Hotels
H
$17.6B
| $23M | 0.05% |
284,142
+160,526
| +130% | +$13.6M |
|
|
APLS
406
DELISTED
Apellis Pharmaceuticals
APLS
| $23M | 0.05% |
336,727
-1,031,680
| -75% | -$61M |
|
|
HHLA
407
DELISTED
HH&L Acquisition Co.
HHLA
| $23M | 0.05% |
2,311,227
| – | – |
|
408
ResMed
RMD
$28.3B
| $22.8M | 0.05% |
104,416
+44,497
| +74% | +$10.1M |
|
409
Church & Dwight Co
CHD
$23.1B
| $22.8M | 0.05% |
318,736
+152,875
| +92% | +$13.2M |
|
|
SCRM
410
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
| $22.6M | 0.05% |
2,333,385
+400,000
| +21% | +$3.86M |
|
411
Camden Property Trust
CPT
$11.3B
| $22.6M | 0.05% |
189,058
+182,265
| +2,683% | +$24.3M |
|
412
Walt Disney
DIS
$165B
| $22.5M | 0.05% |
238,948
+137,111
| +135% | +$14.7M |
|
413
PUT
Salesforce
CRM
$134B
| $22.5M | 0.05% |
+156,200
| New | +$26.5M |
|
|
OKLO
414
Oklo
OKLO
$7B
| $22.5M | 0.05% |
2,300,339
+801,538
| +53% | +$7.79M |
|
415
Exelon
EXC
$48.6B
| $22.4M | 0.05% |
599,086
-142,277
| -19% | -$6.29M |
|
|
HIBB
416
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $22.4M | 0.05% |
448,937
+112,062
| +33% | +$5.88M |
|
417
PUT
Oracle
ORCL
$331B
| $22.3M | 0.05% |
+365,600
| New | +$26.8M |
|
418
Danaher
DHR
$135B
| $22.2M | 0.05% |
+97,138
| New | +$23.8M |
|
|
REVH
419
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
| $22.2M | 0.05% |
2,260,399
+401,191
| +22% | +$3.94M |
|
420
Frontline
FRO
$8.75B
| $22.1M | 0.05% |
2,025,645
+1,022,629
| +102% | +$11.2M |
|
421
Westlake Corp
WLK
$9.46B
| $22M | 0.05% |
+253,380
| New | +$24.3M |
|
422
Agree Realty
ADC
$9.68B
| $21.9M | 0.05% |
+324,417
| New | +$24.4M |
|
|
AGR
423
DELISTED
Avangrid, Inc.
AGR
| $21.8M | 0.05% |
523,958
-38,274
| -7% | -$1.84M |
|
|
TSPQ
424
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $21.8M | 0.05% |
2,226,371
| – | – |
|
425
LSB Industries
LXU
$881M
| $21.7M | 0.05% |
1,520,555
+1,444,842
| +1,908% | +$20.4M |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.